Testing the Combination of Anti-Cancer Drugs Talazoparib and Temozolomide in Patients With Advanced Stage Rare Cancers, RARE 2 Trial

NCT05142241 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

14

Enrollment

NIH

Sponsor class

Conditions

Adrenal Gland Pheochromocytoma
Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm
Paraganglioma

Interventions

PROCEDURE: Biopsy Procedure
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
DRUG: Talazoparib
DRUG: Temozolomide

Sponsor

National Cancer Institute (NCI)